Merck To Kick Off 2nd Round Of Fosamax Suits In NJ

By Greg Ryan (March 1, 2013, 7:39 PM EST) -- Merck & Co. Inc. is set to face trial later this month in New Jersey over claims that its bone drug Fosamax causes femur fractures, as it attempts to replicate the success it has found against claims the drug causes jaw injures.

Potential jurors in the case will fill out a questionnaire at an Atlantic County courthouse on Monday, with jury selection beginning in earnest on March 11. The suit is one of more than 2,000 cases against Merck over Fosamax-related femur injuries in New Jersey state court.

Plaintiffs nationwide have made two types of allegations related to Fosamax: that it...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!